Optimal Time for Pharmacological Treatment of Abdominal Aortic Aneurysm.

Iida, Yasunori; Sawa, Shigeharu; Shimizu, Hideyuki

Iida, Yasunori; Sawa, Shigeharu; Shimizu, Hideyuki.

Affiliation

Iida Y; Department of Cardiovascular Surgery, Keio University, Tokyo, Japan.
Sawa S; Department of Cardiovascular Surgery, Ogikubo Hospital, Tokyo, Japan.
Shimizu H; Department of Cardiovascular Surgery, Ogikubo Hospital, Tokyo, Japan.

Curr Drug Targets ; 19(11): 1297-1301, 2018.

Article in En | MEDLINE | ID: mdl-29284387

Subject(s)

Aorta, Abdominal/pathology; Aortic Aneurysm, Abdominal/drug therapy; Aortic Rupture/drug therapy; Angiotensin II Type 1 Receptor Blockers/therapeutic use; Anti-Bacterial Agents/therapeutic use; Aortic Aneurysm, Abdominal/complications; Aortic Aneurysm, Abdominal/pathology; Aortic Rupture/complications; Aortic Rupture/pathology; Disease Progression; Humans; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Vasodilator Agents/therapeutic use; Watchful Waiting

Key words

Abdominal aortic aneurysm; cardiovascular surgery; chronic inflammation; endovascular aneurysm repair; graft replacement; pharmacological treatment.

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Aorta, Abdominal / Aortic Rupture / Aortic Aneurysm, Abdominal Type of study: Clinical_trials Limits: Humans Language: En Journal: Curr Drug Targets Journal subject: TERAPIA POR MEDICAMENTOS Year: 2018 Document type: Article Affiliation country: Japan Country of publication: United Arab Emirates

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google